Hers vs Mochi Health: Wegovy brand vs compounded, live video visits
The comparison between Hers vs Mochi Health comes down to FDA-approved brand-name GLP-1s and a membership model versus lower-cost compounded options and live video visits. Early verdict: choose Hers if you want FDA-approved Wegovy with a personalized care team; choose Mochi Health if you prioritize lower starting pricing and live, synchronous doctor visits.
How Hers and Mochi Health differ at a glance
Both are telehealth routes to prescription weight loss treatment, but their core approaches differ. Hers markets FDA-approved Wegovy and brand-name GLP-1s with a personalized care team and ongoing dose check-ins. Mochi Health focuses on compounded medications with live video visits and membership-plus-medication pricing, offering a fast 5-minute video booking experience and a promotional 50% Off Your 1st Month with Code BESTWLHALFOFF.
Distinctive differences we compare
- Medication type and regulatory notes
- Pricing structure and starting costs
- Clinical visit model and ongoing care
- State availability and membership requirements
| Criteria | Hers | Mochi Health |
|---|---|---|
| Medication type | FDA-approved Wegovy and brand-name GLP-1s, not compounded | Primarily compounded semaglutide and tirzepatide options |
| Starting price | Wegovy pill from $149/mo; injectable from $199/mo | Compounded semaglutide starting $99/month; promotional pricing available |
| Visit model | Personalized care team with ongoing dose check-ins | Live video visits with a doctor bookable in about 5 minutes |
| Membership | Active Hers Weight Loss Membership required; promotional first month $39 then auto-renews | Membership-plus-medication structure; first month promotional rate $39 for new customers then $79 standard |
| Availability and regulatory notes | Not available in all 50 states; prescription required; no compounded medications offered | Reliable GLP-1 prescription access in all 50 states; compounded medications not FDA-approved |
Medication type: FDA-approved brand versus compounded formulations
In this pair, medication type is a primary divide. Hers advertises FDA-approved Wegovy which it states is not a compounded product. The provider emphasizes name brand medication and notes that compounded medications, when offered elsewhere, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Mochi Health emphasizes compounded semaglutide and tirzepatide options, including a compounded once-weekly semaglutide injection and a compounded oral semaglutide pill. Mochi also repeats the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Pricing and membership: starting costs and how you pay
Hers publishes starting pricing such as Wegovy pill from $149/mo and injectable from $199/mo and states that an active Hers Weight Loss Membership is required, with a promotional $39 first month that auto-renews at $149/month thereafter. The source notes total cost includes membership plus medication and that medication is not available without an active membership. Mochi Health reports membership-plus-medication pricing that starts as low as $99/month and advertises 50% Off Your 1st Month with Code BESTWLHALFOFF and a promotional first month $39 rate for new customers, after which the standard rate is $79 per month. Mochi states ongoing cost varies by plan and medication and that members continue care beyond their first month.
Clinical access and ongoing care: teams versus live video visits
Hers highlights a personalized care team with ongoing dose check-ins as part of its care model. Mochi Health differentiates itself by offering live video visits with a doctor in about 5 minutes, noting that most competitors use asynchronous text review. Mochi says the synchronous video visit allows a real-time conversation where a physician evaluates the case and explains the treatment plan directly, and offers 24/7 support plus ongoing appointment availability.
State availability and prescription conditions
Hers notes not available in all 50 states and that prescriptions are required and subject to clinician review and eligibility. Mochi states reliable GLP-1 prescription access in all 50 states and that a licensed physician evaluates cases during video consultations before any prescription is issued. Both sources include the regulatory reminder that compounded medications are not FDA-approved when relevant.
Final comparison and how to choose
Hers vs Mochi Health separates along medication type, price structure, and visit model. Hers is centered on FDA-approved Wegovy and a personalized care team with required membership and published starting prices. Mochi Health emphasizes lower starting pricing on compounded options, a synchronous live video visit model bookable in about 5 minutes, and promotional first month offers.
Choose Hers if you want FDA-approved Wegovy or other brand-name GLP-1s with a personalized care team and are prepared for a membership requirement and the provider noted state availability limits. Choose Mochi Health if you prefer lower starting costs for compounded semaglutide or tirzepatide, want a live video doctor visit that can be booked in about 5 minutes, and are comfortable with a membership-plus-medication pricing structure and promotional first month terms. Hers vs Mochi Health should be decided based on whether FDA-approved brand medications or compounded, lower-cost options and live synchronous visits matter more to you.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
